glp-1 agonist drugs Receptor Agonists: An Alternative for Rapid-Acting Insulin? GLP-1 Medications for Weight Loss:
Description
The weight loss induced by liraglutide at 3 mg is typically in the range of 510% after 52 wk of treatment of non-diabetic obese patients [895]
doi: 10.14309/ajg.0000000000002820
Real-world evidence on the utilization, clinical and comparative effectiveness, and adverse effects of newer GLP-1RA-based weight-loss therapies
Intervention: Any GLP-1 receptor agonist, including liraglutide, semaglutide, dulaglutide, exenatide, or lixisenatide
Lincoff, M, Brown-Frandsen K, Colhoun H, et al
Body composition and ectopic fat VAT accumulation is strictly linked to various metabolic disturbances and obesity-related cardiovascular diseases [66]
